Table of Contents

September 15, 2023; Volume 20,Issue 9

C

  1. Chen, Jia

    1. Liquid-liquid phase separation in DNA double-strand break repair
      Jia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo Wan
      Cancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252

  2. Chen, Ping

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

  3. Chen, Zhiyu

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

D

  1. Ding, Yuwei

    1. CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
      Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
      Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211

G

  1. Guo, Weijian

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

H

  1. He, Min

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

  2. He, Wei

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

  3. Huang, Mingzhu

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

L

  1. Li, Mengyuan

    1. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
      Mengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin Qian
      Cancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202

  2. Li, Wenhua

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

  3. Li, Zhan

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

  4. Lin, Yilin

    1. Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
      Changjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong Shen
      Cancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201

  5. Liu, Haoyu

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

  6. Liu, Yunhua

    1. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
      Mengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin Qian
      Cancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202

M

  1. Mi, Mi

    1. CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
      Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
      Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211

P

  1. Pan, Yuefen

    1. CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
      Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
      Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211

Q

  1. Qian, Wenbin

    1. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
      Mengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin Qian
      Cancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202

  2. Qiu, Lixin

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

  3. Qiu, Wei

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

S

  1. Shen, Zhanlong

    1. Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
      Changjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong Shen
      Cancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201

  2. Shi, Jie

    1. Liquid-liquid phase separation in DNA double-strand break repair
      Jia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo Wan
      Cancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252

  3. Sun, Weijing

    1. CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
      Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
      Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211

W

  1. Wan, Xiangbo

    1. Liquid-liquid phase separation in DNA double-strand break repair
      Jia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo Wan
      Cancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252

  2. Wang, Chenchen

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

  3. Wang, Shan

    1. Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
      Changjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong Shen
      Cancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201

  4. Wang, Xiaohui

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

  5. Wang, Yunlong

    1. Liquid-liquid phase separation in DNA double-strand break repair
      Jia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo Wan
      Cancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252

  6. Weng, Shanshan

    1. CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
      Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
      Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211

  7. Wu, Zhiqiang

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

X

  1. Xu, Xiang

    1. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
      Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
      Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033

  2. Xu, Ziheng

    1. CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
      Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
      Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211

Y

  1. Yang, Changjiang

    1. Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
      Changjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong Shen
      Cancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201

  2. Yang, Lei

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

  3. Yang, Mengyuan

    1. CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
      Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
      Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211

  4. Ye, Qian

    1. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
      Mengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin Qian
      Cancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202

  5. Ye, Yingjiang

    1. Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
      Changjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong Shen
      Cancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201

  6. Yuan, Ying

    1. CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
      Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
      Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211

Z

  1. Zhang, Minghuan

    1. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
      Mengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin Qian
      Cancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202

  2. Zhang, Wen

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

  3. Zhang, Xiaowei

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

  4. Zhang, Zhe

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

  5. Zhao, Long

    1. Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
      Changjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong Shen
      Cancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201

  6. Zhao, Xiaoying

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

  7. Zheng, Jian

    1. Liquid-liquid phase separation in DNA double-strand break repair
      Jia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo Wan
      Cancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252

  8. Zhu, Xiaodong

    1. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
      Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
      Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Back to top

In this issue

Cancer Biology & Medicine: 20 (9)
Cancer Biology & Medicine
Vol. 20, Issue 9
15 Sep 2023

Submit

Sign up for alerts